
1001 - 5000 employés
Fondée en 2003
🏥 Santé
🏭 Fabrication
🧬 Biotechnologie
Healthcare • Manufacturing • Biotechnology
Jazz Pharmaceuticals est une entreprise biopharmaceutique dédiée au développement de médicaments innovants répondant à des besoins médicaux sérieux non satisfaits. Avec un fort engagement envers la recherche et le développement, Jazz se concentre sur la création de thérapies transformatrices, mettant en avant l'importance de la collaboration, de la diversité et de l'engagement des employés dans ses opérations. L'entreprise est fière de transformer la vie des patients grâce à ses offres de produits significatives et une culture qui favorise l'enthousiasme et la flexibilité.
🕒 il y a 6 jours
🔔 Pennsylvania – Distant
💵 $212 000 - $318 000 / an
⏰ Temps Plein
🔴 Expert
👔 Directeur
🦅 Parrain de Visa H1B
👻 Score fantôme 0%
🗣️🇺🇸🇬🇧 Anglais requis
D'où vient cette offre
Publiée sur la page carrières de Jazz Pharmaceuticals, pas via un site d'emploi
Repérée par Remote Rocketship il y a 6 jours
Toujours ouverte sur le site de Jazz Pharmaceuticals. Vérifiée il y a 1 heure.

1001 - 5000 employés
Fondée en 2003
🏥 Santé
🏭 Fabrication
🧬 Biotechnologie
Healthcare • Manufacturing • Biotechnology
Jazz Pharmaceuticals est une entreprise biopharmaceutique dédiée au développement de médicaments innovants répondant à des besoins médicaux sérieux non satisfaits. Avec un fort engagement envers la recherche et le développement, Jazz se concentre sur la création de thérapies transformatrices, mettant en avant l'importance de la collaboration, de la diversité et de l'engagement des employés dans ses opérations. L'entreprise est fière de transformer la vie des patients grâce à ses offres de produits significatives et une culture qui favorise l'enthousiasme et la flexibilité.
• Define and drive global and US payer evidence strategy for pipeline assets from early clinical development through regulatory approval and launch • Lead global payer evidence generation while serving as the US HEOR lead • Lead US pre-launch HEOR deliverables, payer field enablement tools, and US market access evidence strategies • Translate target product profiles and access ambitions into evidence generation programs, including economic models, natural history studies, Global Value Dossiers, and US AMCP dossiers • Partner with Clinical Development, Biostatistics, and Clinical Operations to integrate payer, formulary, and HTA requirements into Phase 2/3 trial designs • Optimize trial protocols through comparator, inclusion/exclusion criteria, treatment-line, and endpoint recommendations • Integrate PROs, HRQoL, symptom burden scales, and HCRU instruments into pivotal trials • Design rare-disease evidence strategies using natural history data, biomarkers, and external or historical comparators • Architect and lead health economic modeling strategies, including CEAs, BIMs, early conceptual models, and threshold analyses • Direct the design, build, and validation of adaptable global core economic models • Develop US pre-launch evidence roadmaps and lead AMCP PIE dossiers, burden-of-illness dossiers, and US budget impact models • Design payer-facing economic models, evidence decks, and population health tools • Lead HEOR workstreams within Launch Readiness Teams and oversee global launch assets such as GVDs and SLRs • Co-develop EU/INT HTA strategies and analytic packages including ITCs, NMAs, and country model adaptations • Design and execute pre-launch real-world studies, chart reviews, registries, and burden-of-illness evaluations • Serve as a GVHEOR stakeholder in IEGP governance and formulate payer evidence strategies • Develop scientific publication plans, co-author manuscripts, and present findings at major congresses • Mentor junior HEOR scientists, post-doctoral fellows, and matrix colleagues
• Required Master’s degree (MSc, MS, MPH, PhD) in Health Economics, Outcomes Research, Pharmacoeconomics, or a closely related quantitative field • Minimum of 7–10 years of experience in HEOR, Global Value, or Health Economics within the biopharmaceutical industry or a top-tier HEOR consulting firm • Proven track record collaborating with Clinical Development, Commercial Development, and Biostatistics teams to influence Phase 2/3 trial design, comparator choice, trial-based resource use collection, and PRO/HRQoL endpoint selection • Strong familiarity with the US managed care and market access landscape, including commercial payers, Medicare Advantage, Medicare Part D/B, Medicaid, and PBMs • Deep understanding of global HTA frameworks, including EU HTA Regulation/JCA, NICE, G-BA, PBAC, and CADTH • Demonstrated capability to lead HEOR launch-readiness workstreams and deliver GVDs, AMCP PIE dossiers, and global ITCs/NMAs under tight regulatory filing timelines • In-depth knowledge of rare disease drug development evidentiary challenges, including natural history studies, registries, surrogate-to-clinical endpoint translation, external control arms, and specialized HTA pathways • Proven ability to define strategic vision and execute and quality-check complex technical models, statistical analysis plans, and dossier sections • Demonstrated success collaborating with regional HEOR teams, particularly EU/INT teams • Ability to influence cross-functional peers and senior leadership across Clinical Development, Medical Affairs, Market Access, and Commercial without formal authority • Exceptional written and verbal communication skills, with an established record of HEOR and clinical publications in peer-reviewed medical and economic journals, or HTA success • Direct experience leading HEOR strategy and deliverables for pipeline assets, including early Phase 2/3 clinical trial protocol integration, endpoint development, and global launch readiness • Experience managing regional trade-offs on evidence needs as part of Phase 2/3 protocol development • Launch lead for at least 2 assets as US HEOR lead or country-level HTA lead • Hands-on experience designing, overseeing, or adapting health economic models • Experience collaborating with regional HEOR teams to deliver evidence packages supporting HTA readiness and submissions
• Discretionary annual cash bonus or incentive compensation • Discretionary equity grants • Medical insurance • Dental insurance • Vision insurance • 401k retirement savings plan • Flexible paid vacation
Postuler MaintenantAméliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.
🕒 il y a 6 jours
Director leading construction and commissioning of industrial wastewater treatment plants for Probst Group. Managing teams, budgets, contractors, safety, schedules, and project delivery.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 6 jours
Regional Medical Affairs Director leading six MSLs for Tarsus Pharmaceuticals, an eyecare-focused biopharmaceutical company. Driving scientific engagement, KOL relationships, medical strategy, and field execution.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 6 jours
Regional fundraising director growing donor relationships and philanthropic revenue for Texas Tribune journalism and The Waco Bridge. Managing Dallas–Fort Worth and Waco portfolios across Texas.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 6 jours
Assurance M&A integration director leading diligence and integration of acquired accounting practices at Citrin Cooperman. Coordinating teams, systems, staffing, training, and change management.
🇺🇸 États-Unis – Télétravail
💵 $160 000 - $225 000 / an
⏰ Temps Plein
🔴 Expert
👔 Directeur
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 6 jours
Director leading Central Valley Ag’s custom business applications for grain, agronomy, feed, and energy operations. Hands-on engineering leadership across cloud delivery, production systems, and team development.
🗣️🇺🇸🇬🇧 Anglais requis